The insider selling is immaterial in size and involves only directors, not C-suite. No bearish signal. Monitor for any future C-suite selling or a material increase in dollar volume before adjusting stance.
LGND drugs
LGND drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 16 $255.25entry
- T+1 · 5mo ago +3.09%α +4.34% · $263.14
- T+5 · 5mo ago +9.48%α +11.71% · $279.44
- T+20 · 4mo ago +17.91%α +17.71% · $300.97
- T+60 · 2mo ago +13.32%α +12.32% · $289.25
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three directors sold a total of ~$1.95M in LGND shares over a 7-day window, representing only ~0.04% of the company's $5.1B market cap. All sellers are non-C-suite directors, and the sales are trivial relative to market cap, indicating routine portfolio diversification rather than informed selling.
Key Financial Metrics
Key Facts
- Total insider sales of ~$1.95M across 3 directors (Haas, Aryeh, Lamattina) from June 10-12, 2026.
- Sales represent ~0.04% of LGND's $5.1B market cap, well below the 0.1% materiality threshold.
- No C-suite executives (CEO, CFO, etc.) participated in the cluster; all sellers are directors.
- Director Haas exercised derivative options (non-cash) before selling, a common pattern for tax planning.
Financial Impact
~$1.95M in open-market sales, negligible relative to $5.1B market cap
Risk Factors
- None from this cluster; however, continued director selling at higher volumes could signal reduced confidence.
- LGND's stock is near $250; any unexpected negative catalyst (e.g., pipeline setback) could amplify selling.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-LGND-1781572048043 |
Track record
29 reports on LGND
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +38.85% at T+60 after the Apr 14, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $305.74 Now $301.71 −1.32% settles Feb 16
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $306.47 Now $301.71 −1.55% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $308.79 Now $301.71 −2.29% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $308.79 Now $301.71 −2.29% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $316.27 Now $301.71 −4.60% settles Feb 10
- Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $316.83 Now $301.71 −4.77% settles Feb 9
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $314.16 Now $301.71 −3.96% settles Feb 8
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $314.15 Now $301.71 −3.96% settles Feb 5
- Nov 4, 202612d ago 144 Neutral 1/10 Entry $299.00 Now $301.71 +0.91% settles Feb 3
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $299.00 Now $301.71 +0.91% settles Feb 3
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers